An industry pioneer dedicated to Improving Lives with Precision Diagnostics®, Invivoscribe is the global leader in driving international standardization of testing and accelerating patient access to the newest and best cancer treatments. It offers a comprehensive portfolio of molecular assays, reagents, controls and bioinformatics tools used by over 700 clinical laboratories in over 160 countries, and a global network of laboratories offering internationally standardized next generation molecular and flow cytometry panels to support drug development and accelerate drug approvals worldwide.
